Published in Cancer Weekly, March 28th, 2006
According to a study from the United States, "Survival after HCC diagnosis is generally dismal, but there are patients with more favorable outcomes. Racial variation in survival of patients with HCC could be associated with observed differences in survival; however this has not been previously examined. During 1987-2001, HCC patients were identified from 9 Surveillance, Epidemiology, and End-Results registries."
"One- and 3-year survival rates were calculated and compared by race," explained J.A. Davila and colleagues, Michael E. DeBakey...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.